FDA Approves Foundayo, the First Daily Oral GLP-1 Pill

A pill without the timing rules

The FDA approved Foundayo (orforglipron) this year for adults with obesity, or overweight with a weight related condition. It is the first oral GLP-1 medicine you can take any time of day, without fasting around food or water first, according to the FDA and Eli Lilly's announcement.

That matters for your routine. Older GLP-1 pills need an empty stomach and a wait before eating. Foundayo does not. In trials, doses produced weight loss between 7.5% and 11.2% over 72 weeks, versus 2.1% on placebo, per the FDA approval letter. This is an approved medication, not a research compound, and it comes with the same nausea and digestive side effects seen in other GLP-1 drugs.

Common questions

Is Foundayo the same as Ozempic or Wegovy? No. Those are injectable semaglutide. Foundayo is a once daily oral pill with a different molecule, orforglipron.

Do you need to take it on an empty stomach? No. That is the main practical difference. You can take it any time, with or without food or water.

Is orforglipron a research peptide? No. It is a small molecule, not a peptide, and it is now an FDA approved prescription drug.

This article is for education only. It is not medical advice. Compounds discussed here are sold for research purposes. Talk to a licensed clinician before making health decisions.